A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with moderate-to-severe Alcohol Use Disorder (AUD). Participation in this study will last approximately 56 weeks.
Epistemonikos ID: 3e680f63d492c080d6bb0f475dd1535fa7c13552
First added on: Oct 23, 2025